Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialEnya Scanlon, Richard Turkington, Julie Turbitt et al.|ESMO Open|2024Cited by 0